These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37555633)

  • 1. COVIDpro: Database for Mining Protein Dysregulation in Patients with COVID-19.
    Zhang F; Luna A; Tan T; Chen Y; Sander C; Guo T
    J Proteome Res; 2023 Sep; 22(9):2847-2859. PubMed ID: 37555633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVIDpro: Database for mining protein dysregulation in patients with COVID-19.
    Zhang F; Luna A; Tan T; Chen Y; Sander C; Guo T
    bioRxiv; 2022 Sep; ():. PubMed ID: 36203550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoVProt: Toward a Mass Spectrometry Data Portal for COVID-19 Proteomics Research and Development.
    Rajoria S; Kavuru SR; Pyda HS; Bihani S; Borishetty D; Biswas D; Prajapati J; Paladi H; Srivastava S
    OMICS; 2024 Jan; 28(1):24-31. PubMed ID: 38193774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
    Zhou N; Bao J; Ning Y
    BMC Bioinformatics; 2021 Jan; 22(1):18. PubMed ID: 33413085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19.
    Zoodsma M; de Nooijer AH; Grondman I; Gupta MK; Bonifacius A; Koeken VACM; Kooistra E; Kilic G; Bulut O; Gödecke N; Janssen N; Kox M; Domínguez-Andrés J; van Gammeren AJ; Ermens AAM; van der Ven AJAM; Pickkers P; Blasczyk R; Behrens GMN; van de Veerdonk FL; Joosten LAB; Xu CJ; Eiz-Vesper B; Netea MG; Li Y
    Front Immunol; 2022; 13():1027122. PubMed ID: 36405747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.
    Amiri-Dashatan N; Koushki M; Rezaei-Tavirani M
    OMICS; 2022 Jan; 26(1):19-34. PubMed ID: 35005991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic characteristics of the treatment trajectory of patients with COVID-19.
    Li X; Ding G; Li S; Liu C; Zheng X; Luo J; He S; Zeng F; Huang X; Zeng F
    Arch Virol; 2024 Mar; 169(4):84. PubMed ID: 38532129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.
    Park A; Harris LK
    Front Immunol; 2021; 12():694355. PubMed ID: 34367154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
    Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
    EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery Proteomics for COVID-19: Where We Are Now.
    McArdle A; Washington KE; Chazarin Orgel B; Binek A; Manalo DM; Rivas A; Ayres M; Pandey R; Phebus C; Raedschelders K; Fert-Bober J; Van Eyk JE
    J Proteome Res; 2021 Oct; 20(10):4627-4639. PubMed ID: 34550702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network.
    Sahin AT; Yurtseven A; Dadmand S; Ozcan G; Akarlar BA; Kucuk NEO; Senturk A; Ergonul O; Can F; Tuncbag N; Ozlu N
    Proteomics Clin Appl; 2023 Mar; 17(2):e2200070. PubMed ID: 36217943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
    Li J; Guo M; Tian X; Wang X; Yang X; Wu P; Liu C; Xiao Z; Qu Y; Yin Y; Wang C; Zhang Y; Zhu Z; Liu Z; Peng C; Zhu T; Liang Q
    Med; 2021 Jan; 2(1):99-112.e7. PubMed ID: 32838362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates with Vaccine Protective Capacity and COVID-19 Disease Symptoms Identified by Serum Proteomics in Vaccinated Individuals.
    Villar M; Urra JM; Artigas-Jerónimo S; Mazuecos L; Contreras M; Vaz-Rodrigues R; Rodríguez-Del-Río FJ; Gortázar C; de la Fuente J
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications.
    Tan HW; Xu YM; Lau ATY
    Expert Rev Proteomics; 2021 Nov; 18(11):925-938. PubMed ID: 34812694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-positive patients display considerable differences in proteome diversity in urine, nasopharyngeal, gargle solution and bronchoalveolar lavage fluid samples.
    Okendo J; Musanabaganwa C; Mwangi P; Nyaga M; Onywera H
    PLoS One; 2022; 17(8):e0271870. PubMed ID: 35939435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods.
    Yu S; Li X; Xin Z; Sun L; Shi J
    Front Immunol; 2022; 13():923387. PubMed ID: 36203586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.